Is Surgery the Only Fate of the Patient with Leriche Syndrome? Our Endovascular Therapy Results Early Follow-Up Outcomes

Authors

  • Metin Onur Beyaz Hatay Mustafa Kemal University Tayfur Ata Sökmen Faculty of Medicine, Department of Cardiovascular Surgery
  • Senem Urfalı Hatay Mustafa Kemal University Tayfur Ata Sökmen Medical Faculty, Department of Anesthesia and Reanimation
  • Sefer Kaya Hatay Mustafa Kemal University Tayfur Ata Sökmen Faculty of Medicine, Department of Cardiovascular Surgery
  • Dilan Oruç Hatay Mustafa Kemal University Tayfur Ata Sökmen Faculty of Medicine, Department of Cardiovascular Surgery
  • İyad Fansa Hatay Mustafa Kemal University Tayfur Ata Sökmen Faculty of Medicine, Department of Cardiovascular Surgery

DOI:

https://doi.org/10.1532/hsf.4691

Keywords:

Leriche syndrome, Endovascular treatment, Chronic aorto-iliac occlusive disease

Abstract

Aim: In this research, we aimed to present early follow-up results of the endovascular treatment in patients with Leriche syndrome at our single center.

Methods and materials: Between October 2020 and January 2022, 14 patients with Leriche syndrome (12 men, two women) who underwent endovascular treatment at our center retrospectively were evaluated. Before the treatment, the ankle-brachial index (ABI) was found 0.50 ± 0.11 on the right leg and 0.45 ± 0.09 on the left leg.

Results: All of the patients with Leriche syndrome applied to our clinic for the first time. In five patients, the fully occluded lesion length was over 3 cm (ranging between 3.5-7.2 cm), hence they were treated with aortic and bilateral iliac bare metallic stents. Although in one patient, the aortic occluding lesion was below 3 cm; it was treated with a bare aortic and bilateral bare iliac stent application because the lesion in the aorta was too calcific. In eight patients, the lesion length was less than 3 cm, bilateral iliac metal bare stents were applied in a kissing stent way.

Conclusion: Endovascular therapy for chronic aorto-iliac occlusive disease has an early high technical success with primary and secondary patency rates. Especially in patients with high risk factors, it may be considered as a good alternative to conventional surgery.

References

Brown KN, Muco E, Gonzalez L. 2021. Leriche Syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.

de Vries SO, Hunink MG. 1997. Results of aortic bifurcation grafts for aortoiliac occlusive disease: a meta-analysis. J Vasc Surg. 26, pp. 558-569.

Etezadi V, Benenati JF, Patel PJ, Patel RS, Powell A, Katzen BT. 2010. The reentry catheter: a second chance for endoluminal reentry at difficult lower extremity subintimal arterial recanalizations. J Vasc Interv Radiol. May; 21(5):730-4.

Indes JE, Mandawat A, Tuggle CT, Muhs B, Sosa JA. 2010. Endovascular procedures for aorto-iliac occlusive disease are associated with superior short-term clinical and economic outcomes compared with open surgery in the inpatient population. J Vasc Surg. Nov; 52(5):1173-9, 1179.e1.

Kashyap VS, Pavkov ML, Bena JF, Sarac TP, O'Hara PJ, Lyden SP, Clair DG. 2008. The management of severe aortoiliac occlusive disease: endovascular therapy rivals open reconstruction. J Vasc Surg. Dec; 48(6):1451-7, 1457.e1-3.

Kim TH, Ko YG, Kim U, Kim JS, Choi D, Hong MK, et al. 2011. Outcomes of endovascular treatment of chronic total occlusion of the infrarenal aorta J Vasc Surg. 53, pp. 1542-1549.

Kondo Y, Dardik A, Muto A, Koizumi J, Nishibe M, Nishibe T. 2010. Primary stent placement for iliac artery chronic total occlusions. Surg Today. May; 40(5):433-9.

Krankenberg H, Schlüter M, Schwencke C, Walter D, Pascotto A, Sandstede J, et al. 2009. Endovascular reconstruction of the aortic bifurcation in patients with Leriche syndrome. Clin Res Cardiol. 98, pp. 657-664.

Leriche R and Morel A. 1948. The syndrome of thrombotic obliteration of the aortic bifurcation. Annals of surgery. 127.2: 193.

Mangialardi N, et al. 2014. Endovascular management of total juxtarenal aortic occlusive disease in high-risk patients: technical considerations and clinical outcome. The Journal of cardiovascular surgery. 58.3: 422-430.

Marrocco-Trischitta MM, Bertoglio L, Tshomba Y, Kahlberg A, Marone EM, Chiesa R. 2012. The best treatment of juxtarenal aortic occlusion is and will be open surgery. J Cardiovasc Surg (Torino). Jun; 53(3):307-12.

Matsuura H, Honda H. 2021. Leriche syndrome. Cleve Clin J Med. Sep 1;88(9):482-483.

Mavioglu I, et al. 2003. Surgical management of chronic total occlusion of abdominal aorta. Journal of Cardiovascular Surgery. 44.1: 87.

Mwipatayi BP, Sharma S, Daneshmand A, Thomas SD, Vijayan V, Altaf N, Garbowski M, Jackson M. 2016. COBEST co-investigators. Durability of the balloon-expandable covered versus bare-metal stents in the Covered versus Balloon Expandable Stent Trial (COBEST) for the treatment of aortoiliac occlusive disease. J Vasc Surg. Jul;64(1):83-94.e1.

Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. 2007. TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. Jan; 45 Suppl S:S5-67.

Onur-Beyaz M, Demir İ, Ozer-Ulukan M. 2021. Comparison of atherectomy, drug-eluting balloon, and combined treatment efficiency by near infrared spectroscopy. Cir Cir. 89(3):342-346.

Oztas DM, Erdinc I, Beyaz MO, Onalan MA, Badem S, Ulukan MO, Unal O, Conkbayir C, Ugurlucan M. 2021. Issues during coronary and visceral revascularization in patients with Leriche syndrome and thoracoabdominal aneurysm. J Card Surg. Mar; 36(3):1168-1169.

Schmalstieg J, et al. 2012. Long term data of endovascularly treated patients with severe and complex aortoiliac occlusive disease. The Journal of cardiovascular surgery. 53.3: 291-300.

Taeymans K, Groot Jebbink E, Holewijn S, Martens JM, Versluis M, Goverde PCJM, Reijnen MMPJ. 2018. Three-year outcome of the covered endovascular reconstruction of the aortic bifurcation technique for aortoiliac occlusive disease. J Vasc Surg. May; 67(5):1438-1447.

Ye W, Liu CW, Ricco JB, Mani K, Zeng R, Jiang J. 2011. Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions. J Vasc Surg. Jun; 53(6):1728-37.

Published

2022-10-12

How to Cite

Beyaz, M. . O., Urfalı, S., Kaya, S., Oruç, D. ., & Fansa, İyad. (2022). Is Surgery the Only Fate of the Patient with Leriche Syndrome? Our Endovascular Therapy Results Early Follow-Up Outcomes. The Heart Surgery Forum, 25(5), E721-E725. https://doi.org/10.1532/hsf.4691

Issue

Section

Articles